Table 2.
Incremental area under the curve (AUC) after intravenous glucose and intravenous arginine stimulation
LRYGB |
LSG |
p value1 |
|||||
---|---|---|---|---|---|---|---|
before surgery | 1 month after surgery | before surgery | 1 month after surgery | pre/post | OP type | pre/post-surgery•OP-type interaction | |
Glucose, mmol/L | |||||||
Glucose stim. | |||||||
AUC0–60 min | 70±10 | 141+18, p = 0.0162 | 126±17 | 132±12, p = 0.7522 | 0.006 | 0.797 | 0.113 |
Arginine stim. | |||||||
AUC0–60 min | –50±12 | 21±11, p = 0.0112 | –17±13 | 2±10, p = 0.1852 | 0.005 | 0.956 | 0.064 |
Insulin, µU/mL Glucose stim. | |||||||
AUC0–60 min | 1,389±296 | 1,452±166, p = 0.8522 | 1,821±359 | 1,639±451, p = 0.7782 | 0.420 | 0.140 | 0.325 |
AUC0–10 min (phase I) | 446±134 | 547±89, p = 0.3112 | 468±126 | 495±91, p = 0.8262 | 0.841 | 0.209 | 0.314 |
AUC10–60 min (phase II] | 943±183 | 905±125, p = 0.8842 | 1,353±254 | 1,144±389, p = 0.6912 | 0.345 | 0.327 | 0.338 |
Arginine stim. | |||||||
AUC0–60 min | 250±248 | 628±272, p = 0.0452 | 428±225 | 641±261, p = 0.0832 | 0.440 | 0.441 | 0.056 |
AUC0–10 min (phase I] | 566±66 | 593±65, p = 0.7682 | 529±79 | 547±84, p = 0.8692 | 0.573 | 0.872 | 0.968 |
AUC10–60 min (phase II] | –316±190 | 35±243, p = 0.2912 | –133±265 | 94±202, p = 0.0202 | 0.218 | 0.271 | 0.841 |
Glucagon, pg/mL | |||||||
Arginine stim. | |||||||
AUC0–60 min | –443±164 | –222±262, p = 0.3762 | –341±93 | –172±122, p = 0.5792 | 0.876 | 0.551 | 0.538 |
C-peptide3, ng/mL | |||||||
Glucose stim. | |||||||
AUC0–45 min | 37±14 | 28±13, p = 0.6912 | 41±12 | 38±13, p = 0.7332 | 0.733 | 0.674 | 0.652 |
Amylin, pmol/L | |||||||
Glucose stim. | |||||||
AUC0–60 min | 58±85 | 32±46, p = 0.7502 | 115±151 | 61±60, p = 0.6642 | 0.680 | 0.096 | 0.580 |
AUC0–30 min | 46±49 | 51±33, p = 0.9032 | 80±94 | 54±36, p = 0.7102 | 0.526 | 0.046 | 0.332 |
AUC0–30 min | 44±19 | 49±28, p = 0.8762 | 122±44 | 61±26, p = 0.3242 | 0.990 | 0.152 | 0.970 |
Data are given as means ± SEM. Statistically significant p values are italicized. LSG, laparoscopic sleeve gastrectomy; LRYGB, laparoscopic Roux-en-Y gastric bypass; BMI, body mass index; HOMA-IR, homoeostasis model assessment insulin resistance; stim., stimulation.
p values derived by general linear model analysis.
For each OP type, pre/post comparison was done by repeated measures analysis of variance (after surgery vs. before surgery).
C-peptide values are available in 7 subjects per group.